A novel [(89)Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer

BACKGROUND: Harnessing the anti-tumor immune system response by targeting the program cell death protein (PD-1) and program cell death ligand protein (PD-L1) axis has been a major breakthrough in non-small cell lung cancer (NSCLC) therapy. Nonetheless, conventional imaging tools cannot accurately as...

Descripción completa

Detalles Bibliográficos
Autores principales: Puyalto, Ander, Rodríguez-Remírez, María, López, Inés, Iribarren, Fabiola, Simón, Jon Ander, Ecay, Marga, Collantes, María, Vilalta-Lacarra, Anna, Francisco-Cruz, Alejandro, Solórzano, Jose Luis, Sandiego, Sergio, Peñuelas, Iván, Calvo, Alfonso, Ajona, Daniel, Gil-Bazo, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569300/
https://www.ncbi.nlm.nih.gov/pubmed/37841258
http://dx.doi.org/10.3389/fimmu.2023.1272570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569300/
https://www.ncbi.nlm.nih.gov/pubmed/37841258
http://dx.doi.org/10.3389/fimmu.2023.1272570

Ejemplares similares